Filter Results:
(1,000)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
Show Results For
- All HBS Web
(1,000)
- People (4)
- News (260)
- Research (614)
- Events (9)
- Multimedia (24)
- Faculty Publications (397)
- Portrait Project
Sarah Assayag
I would become the first colony settler on Earth 2.0, develop drugs that would allow humans to become immortal, and create an android that would fall asleep by counting electric sheep. My 8-year-old self, inspired by science fiction,... View Details
Charles R. Walgreen
Though Walgreen was trained as a pharmacist, he was an equally astute businessman. Walgreen personally manufactured some of his drugs in order to be able to maintain profitable low prices, and he also offered Walgreens branded merchandise... View Details
Keywords: Retail
- 16 Sep 2016
- News
Gaining Ground on ALS
Bucket Challenge to support the Phase 3 trial of a promising investigational drug that is designed to slow the loss of lung function and muscle strength in patients with ALS. “Clinical trials cost tens to hundreds of millions of dollars,”... View Details
- Web
Consumer Information | MBA
Disabilities Career and Professional Development Drug and Alcohol Prevention Retention and Graduation Rates Campus Security Fire Safety Student Records Policy (FERPA) University Wide Consumer Information View Details
- Web
HBS Magazine - Alumni
Career-Retirement Psychology-Behavior Career-Career Changes After Ozempic How a game-changing drug is reshaping Novo Nordisk, disrupting the pharma industry, and setting up a once-in-a-generation windfall for philanthropy View Story... View Details
- 01 Dec 2013
- News
To Market, to Market
chirality) of drug molecules with a high degree of accuracy for drug development and diagnostic applications. Chemical compounds excreted by predators that stimulate avoidance behavior in disease-carrying... View Details
- 01 Dec 2006
- News
Faculty Books
from its character as a science-based business. This poses three challenges: how to finance risky investments with long time horizons for R&D; keep pace with advances in drug knowledge; and integrate capabil-ities across the spectrum of... View Details
- 01 Mar 2011
- News
Wyss Celebrated for Career, Conservation
orthopedic and trauma surgery. He continues to serve as chairman. In recognition of his career, the HBS Health Industry Alumni Association presented Wyss with the Beatrice D. Ellerin Alumni Achievement Award at its annual conference in November (see article "Fixing... View Details
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable biological View Details
- Web
Suppliers - Institute For Strategy And Competitiveness
carefully examine the outcomes relative to cost for every new drug and device introduced. Key Action Steps for Suppliers Base strategies on creating unique value for patients Focus on cycles of care rather than narrow product usage Sell... View Details
- 01 Sep 2008
- News
In Africa, Porter Sees Lessons for Health Care
delivery systems of both developing and advanced countries: fragmentation, inefficiency, and organization around discrete interventions (such as delivering drugs or screening) rather than integrated care. Porter and his colleagues aim to... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
time, Imprimis was in the process of seeking FDA approval for a branded drug called Impracor. This process, already difficult, was further complicated by recent manufacturing issues. Meanwhile, the opportunity arose for Imprimis to... View Details
Keywords: Sean Silverthorne
- Web
2. Integrity & Standards of Conduct | MBA
of Conduct 2.3 Community Standards of Conduct 2.3.1 Drug & Alcohol Policy 2.3.2 Hazing 2.3.3 Non-Discrimination & Anti-Bullying 2.3.4 Sexual & Gender Based Harassment & Other Sexual Misconduct 2.3.5 Research Misconduct 2.3.6 Dangerous... View Details
- 01 Sep 2011
- News
Alumni Team Up to Fight Cancer
networking among its alumni community. Bowes, founding partner of US Venture Partners, and Giusti, founder of the Multiple Myeloma Research Foundation (MMRF), discussed the need for innovative, results-oriented biomedical research and View Details
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
can redefine the Health care industry and sparked my interest in exploring how the public and private sectors can work together to improve patient outcomes. With the summer internship search heating up, I am excited to explore opportunities as an intern at the Food and... View Details
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
for everyone and also highlighted the important link between research, discovery, and cure." The GPP is a statewide prevention program aimed at reducing the use of dangerous drugs among teens and young adults through awareness campaigns,... View Details
- 01 Jun 2003
- News
Against All Odds
never accomplished by any other European country, despite 150 years of trying). If it sounds almost as difficult as bringing a profitable drug to market, maybe that’s why Ernesto Bertarelli (MBA ’93), CEO of the Swiss biotech company... View Details
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
quickly," he observes. Under his guidance, Novartis has been a leader not only in developing new drugs but in making them accessible to those in need around the globe. Dan Vasella has experienced first-hand the anguish of seriously ill... View Details
- Profile
Max Seel
"that have unique bonding properties relevant to drug delivery." The other encounter became "the most life-changing experience" of his life: serving as a personal aide to a retired professor with Parkinson's disease.... View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details